Yale Cancer Center and our partner, Smilow Cancer Hospital, acknowledge the seven American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) evidence-based quality guidelines for breast and colorectal cancers. The latest performance data for colorectal cancer is listed below.
|Colorectal Measures||Expected Estimated Performance Rates (percentage)||Yale Performance 2012||Yale Performance 2013||Yale Performance 2014|
|Adjuvant chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC stage III (lymph node positive) colon cancer (Accountability)||90%||95.00||100.00||90.60|
**Higher percentage is better